Testosterone, Men's Health, and TRT: What the Evidence Says and What Is Just Marketing
Total testosterone falls by about 1.2 to 1.6 percent per year after age 30, diagnosing deficiency requires at least two repeated morning tests, and TRT is a decision that requires medical supervision. The TRAVERSE trial in 2023 found TRT did not raise major cardiac events or prostate cancer, but signals remain to watch, and most supplements work only in people already deficient in that nutrient

Have you seen the clips claiming that taking this one thing makes testosterone surge, or that TRT is the key to a longer life for men?
Testosterone is an easy topic to sell and a high-stakes one to get wrong, so it helps to separate what genuinely passes real research from what is just a sales pitch. This article walks through it one piece at a time: the decline with age, getting the diagnosis right, the safety of TRT for the heart and the prostate, and which supplements work and which do not.
Confirmed total testosterone below 300 ng/dL together with clear symptoms is the threshold to start TRT under the Endocrine Society 2018 guideline. A low number on its own, without symptoms, is not a reason to start hormones.
A Three-Line Summary
- Total testosterone falls by about 1.2 to 1.6 percent per year after age 30, and diagnosing deficiency requires repeated fasting morning tests at least twice before starting treatment.
- The TRAVERSE trial in 2023 found TRT did not raise major cardiac events and did not raise prostate cancer, but it did find atrial fibrillation, blood clots, and fractures as signals that still need watching and follow-up.
- Most supplements work only in people already deficient in that nutrient, such as zinc in zinc-deficient men, while Tribulus and ZMA do not move testosterone in healthy men.
Testosterone Declines With Age, and the Normal Range Is Not One Number
After age 30, total testosterone slowly falls by about 1.2 to 1.6 percent per year. This figure comes from the longitudinal Baltimore Longitudinal Study of Aging, which followed the same group of men over time, and it is higher than the figure from cross-sectional studies that photograph different groups at a single point in time.
The normal testosterone level in men aged 20 to 44 is about 350 to 575 ng/dL depending on age, per the Journal of Urology 2022.
A common point of confusion is the 300 ng/dL threshold. That number was designed from middle-aged to older men, and using it on younger men can miss the diagnosis. The Journal of Urology 2022 therefore proposed a higher age-specific cutoff for younger men, in the range of about 350 to 413 ng/dL across age bands.
Diagnosing Hypogonadism and the Threshold to Start TRT
Hypogonadism, the condition where the body produces less testosterone than normal, is diagnosed by measuring total testosterone in the fasting morning state, repeated at least twice before starting treatment, per the Endocrine Society Clinical Practice Guideline 2018.
The threshold to start TRT is having symptoms and signs of testosterone deficiency together with a confirmed total testosterone below 300 ng/dL. Both must be present, under the same guideline. Having a low number alone, without symptoms, is not a reason to start hormones.
Before starting, contraindications must be checked, including prostate cancer and a hematocrit above 50 percent (hematocrit is the proportion of red blood cells in the blood), per Endocrine Society 2018.
Erythrocytosis, a rise in red blood cells that thickens the blood, is the most common side effect of TRT, because TRT pushes hematocrit up, so blood values must be monitored regularly. This is one reason TRT requires ongoing medical care, not something to buy and use on your own.
Fertility and Testicular Shrinkage Can Reverse
TRT causes the testicles to shrink and reduces sperm production. These changes are mostly reversible, with testicular size usually returning to normal within about 6 to 12 months after stopping TRT, per clinical case series.
If you still want to have children, this matters and should be discussed with a doctor before starting, because the recovery time in middle-aged adults is not yet well documented.
The TRAVERSE Trial 2023: Cardiac Safety and Prostate Cancer
TRAVERSE is the large trial that answered whether TRT is safe for the heart, published in NEJM 2023.
The main result is that TRT did not increase the incidence of major adverse cardiovascular events, known as MACE, which is the group of severe cardiac events such as heart attack, stroke, and cardiac death.
But the trial found two signals to watch: atrial fibrillation (irregular heartbeat) rose to 3.5 percent versus 2.4 percent, and blood-clot events to 1.7 percent versus 1.2 percent in the TRT group. Both are secondary outcomes, not the main result, so they require confirmatory follow-up.
On prostate cancer, TRT used according to the guideline did not raise the risk of new cancer, with an incidence of 1.3 percent in the TRT group versus 1.5 percent in the placebo group.
The Surprising Story About Bone
A TRAVERSE substudy found that TRT increased bone mineral density, or BMD, by about 4 to 7 percent, which sounds good, yet it also found more fractures, at 3.9 percent in the TRT group versus 2.8 percent in the placebo group.
⚠️ caveat: the mechanism is unclear. About 80 percent of the fractures came from falls, and the higher incidence may be because men on TRT feel better and become more active, giving them more chances to fall. This part of the data is still being debated and needs deeper and longer study.
How Much Do Exercise and Weight Loss Help
Resistance training raises testosterone acutely, meaning it rises during and after exercise, especially high-intensity training that uses large muscle groups.
Chronic testosterone levels depend on several things together: losing body fat, sleep, and managing stress, not exercise alone.
Weight loss genuinely helps, because there is a two-way relationship between excess fat and low testosterone. Observational data show that losing 1 kilogram raises total T by about 0.6 percent, and losing 10 percent of body weight raises the share of men with normal T from 53 percent to 77 percent. The effect size seen in real RCTs is more modest than popular health articles often suggest (details in the points to watch).
Supplements: What Works and What Does Not
The simple rule is that most supplements work only when you are already deficient in that nutrient.
| Supplement | Evidence | Works for whom |
|---|---|---|
| Tongkat Ali | systematic review meta-analysis supports it | men with low T, mostly older |
| Zinc | systematic review supports it | men who are zinc-deficient specifically |
| Tribulus terrestris | 8 of 10 studies found no change | does not move in healthy men |
| ZMA | most studies found no effect | no rise in men with enough zinc |
| Fenugreek | mixed results, see points to watch | unclear versus placebo |
| Vitamin D | raises total T but not free T | still debated, see points to watch |
Tongkat Ali has evidence for raising testosterone in men with low T, and zinc raises testosterone in men who are specifically zinc-deficient, while Tribulus has no effect in healthy men and ZMA does not raise testosterone in men who already have enough zinc.
Free Testosterone Versus Total Testosterone
Total testosterone is the whole amount, while free testosterone is only about 2 to 4 percent of the total, yet it is the most biologically active part.
Bioavailable testosterone, which is free plus the part bound to albumin, is about 30 to 55 percent and should be measured in men whose total T is near the low threshold or who have abnormal SHBG.
⚠️ caveat: measuring bioavailable T is mostly a calculation, not a direct assay, and its clinical predictive value still differs by condition, across hypogonadism, prostate cancer, and frailty.
Points to Watch: Beliefs the Evidence Does Not Support
“Weight loss raises testosterone by 30 percent”
The 30 percent figure comes from popular health reviews, not peer-reviewed clinical trials. The real data show that losing 1 kilogram raises total T by about 0.6 percent, and losing 10 percent of body weight raises the share of men with normal T from 53 percent to 77 percent. The true effect is smaller than popular articles claim.
“Men aged 20 to 44 can use the 300 ng/dL threshold like middle-aged men”
The 300 ng/dL figure was designed from middle-aged to older men. The Journal of Urology 2022 indicates that younger men should use a higher age-specific cutoff. Using 300 ng/dL on younger men may underdiagnose, yet clinical guidelines still use 300 for historical reasons.
“Vitamin D raises usable testosterone”
A 2024 meta-analysis of 17 studies found that vitamin D may raise total T but does not significantly affect free T, FSH, LH, or SHBG. A rise in total T does not mean bioavailable T rises with it.
“Fenugreek raises the free testosterone index by 12.2 percent clearly”
A 2024 RCT found that the highest dose of 1800 mg raised the FTI by 12.2 percent versus baseline significantly, but compared with placebo the difference was not significant. This figure should be read with caution.
“Tongkat Ali works for every healthy young man”
Most studies were done in older men or men with low T, and the effect in men aged 20 to 44 or in healthy men is not yet proven. The result depends on the population.
What Is Still Unknown and Needs Follow-Up
- The biochemical mechanism of the fracture risk in TRAVERSE despite rising BMD may relate to bone quality, turnover, or microarchitecture more than density alone.
- The atrial fibrillation signal in TRAVERSE, at 3.5 versus 2.4 percent, is a secondary outcome that needs post-hoc follow-up to confirm.
- The target testosterone range that is right for TRT, often cited as 500 to 800 ng/dL, is not clearly evidence-based versus empirical.
- The cutoff that fits men aged 20 to 44 specifically remains an open question, because 300 ng/dL may be too low yet guidelines still use it.
A Small Step You Can Take
If you suspect you have symptoms of low testosterone, such as low energy, reduced libido, or muscle loss, talking to a doctor and getting a morning blood test gives a better picture than guessing or trusting an advertising clip. TRT is not something you can start on your own, because it requires a confirmed repeated diagnosis, a check of contraindications, and continuous monitoring of blood values. As for longevity, there is no strong evidence that TRT makes men live longer. This is managing hormones with understanding, not following a sales pitch.
This article is for understanding, not medical advice, and you should consult a doctor before deciding to start TRT



Read next
More in this category

Endometriosis: What It Is, Why It Hurts, and How to Manage It
A short guide to endometriosis, covering what it is, why it causes severe period pain and pelvic pain, why it so often takes years to diagnose, how it is diagnosed, and how to start looking after yourself alongside your doctor.
Read article
Hyperthyroidism and Graves' Disease: What It Is, the Symptoms, and How to Manage It
A short guide to hyperthyroidism and Graves' disease, covering what an overactive thyroid is, how Graves' disease fits in, the symptoms to watch for, how it is diagnosed, why it should not be left untreated, and how to start looking after yourself.
Read article
PCOS and Insulin Resistance: What It Is, How It Is Diagnosed, and How to Manage It
A short guide to PCOS and insulin resistance, covering what PCOS is, how high insulin drives up male hormones, how the Rotterdam criteria diagnose it, why it needs long term care, and how to start looking after yourself.
Read articleVerifiable
References for this article
- 1 Bioavailable Testosterone Linearly Declines Over A Wide Age Spectrum, Baltimore Longitudinal Study of Aging (PMID 26921861, DOI 10.1093/gerona/glw021) pubmed.ncbi.nlm.nih.gov
- 2 Testosterone Therapy in Men With Hypogonadism: Endocrine Society Clinical Practice Guideline 2018 (PMID 29562364, JCEM Vol 103 Issue 5, Bhasin et al.) pubmed.ncbi.nlm.nih.gov
- 3 Cardiovascular Safety of Testosterone-Replacement Therapy, The TRAVERSE Trial (PMID 37326322, DOI 10.1056/NEJMoa2215025, NEJM 2023) pubmed.ncbi.nlm.nih.gov
- 4 What Is a Normal Testosterone Level for Young Men? Journal of Urology (PMID 36282060, DOI 10.1097/JU.0000000000002928) pubmed.ncbi.nlm.nih.gov
- 5 The Impact of Vitamin D on Androgens and Anabolic Steroids among Adult Males: A Meta-Analytic Review (PMID 39452471, PMC11506788) pubmed.ncbi.nlm.nih.gov
Reviewed by Health Coach: A888